Picton Mahoney Asset Management bought a new stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm bought 12,176 shares of the company's stock, valued at approximately $369,000.
A number of other large investors have also recently modified their holdings of BBWI. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Bath & Body Works by 1.5% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 53,593 shares of the company's stock valued at $1,625,000 after acquiring an additional 809 shares in the last quarter. Cetera Investment Advisers boosted its holdings in shares of Bath & Body Works by 8.9% during the 1st quarter. Cetera Investment Advisers now owns 27,091 shares of the company's stock valued at $821,000 after acquiring an additional 2,214 shares in the last quarter. Royce & Associates LP boosted its holdings in shares of Bath & Body Works by 22.8% during the 1st quarter. Royce & Associates LP now owns 40,423 shares of the company's stock valued at $1,226,000 after acquiring an additional 7,505 shares in the last quarter. Legato Capital Management LLC acquired a new stake in shares of Bath & Body Works during the 1st quarter valued at $663,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Bath & Body Works during the 1st quarter valued at $807,000. Institutional investors and hedge funds own 95.14% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on BBWI shares. UBS Group raised their price objective on Bath & Body Works from $32.00 to $36.00 and gave the company a "neutral" rating in a report on Tuesday, May 20th. Barclays cut their price objective on Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating on the stock in a report on Friday, May 30th. Wall Street Zen raised Bath & Body Works from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. The Goldman Sachs Group lowered their target price on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research report on Friday, May 30th. Finally, Citigroup raised their target price on Bath & Body Works from $36.00 to $42.00 and gave the stock a "buy" rating in a research report on Tuesday, May 20th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $42.19.
Get Our Latest Stock Analysis on BBWI
Bath & Body Works Stock Performance
Shares of BBWI stock traded down $0.81 during mid-day trading on Friday, hitting $28.15. The company's stock had a trading volume of 8,824,095 shares, compared to its average volume of 4,515,115. The company's fifty day simple moving average is $29.81 and its 200-day simple moving average is $31.88. Bath & Body Works, Inc. has a 52 week low of $24.94 and a 52 week high of $41.87. The company has a market cap of $5.96 billion, a PE ratio of 7.51, a P/E/G ratio of 0.96 and a beta of 1.54.
Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its earnings results on Thursday, May 29th. The company reported $0.49 EPS for the quarter, beating analysts' consensus estimates of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%. The business had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.42 billion. During the same period in the previous year, the company posted $0.38 EPS. The firm's revenue was up 2.9% compared to the same quarter last year. On average, equities analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.
Bath & Body Works Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, June 20th. Investors of record on Friday, June 6th were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Friday, June 6th. Bath & Body Works's payout ratio is presently 21.33%.
Bath & Body Works Company Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Articles

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.